Unibest

Pharmaceutical intermediates

Aripiprazole Intermediates

2 pharmaceutical intermediates for Aripiprazole. Indication: Autism spectrum disorder; Mania; Severe depression; Schizophrenia; Tourette's disorder.

提交项目All intermediates

About Aripiprazole

Originator
Otsuka Pharmaceutical Co Ltd
Indication
Autism spectrum disorder; Mania; Severe depression; Schizophrenia; Tourette's disorder
Approved Date
11/15/2002
DS/DP
07/28/2026

Available intermediates

2 intermediates currently listed for Aripiprazole. Request specifications, documentation or a quotation for any item below.

Aripiprazole intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone129722-34-5//
1-(2,3-Dichlorophenyl)piperazine hydrochloride119532-26-2//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Aripiprazole?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →